2025. A Comparative Study of The Effectiveness of Pfizer-BioNTech (BNT162b2), AstraZeneca (ChAdOx1nCoV-19) and Sinopharm (BBIBP-CorV) Vaccines in Eliciting Cell Mediated and Humoral Immunity in A Sample of Vaccinated Population from Iraq. Iraqi Journal of Medical Sciences. 22, 2 (Jan. 2025).